Viewing Study NCT06863259


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-01-25 @ 4:50 AM
Study NCT ID: NCT06863259
Status: RECRUITING
Last Update Posted: 2025-06-13
First Post: 2025-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None B-ALL View
None B-cell Acute Lymphoblastic Leukemia View